The country’s first legislation on land acquisition, rehabilitation and resettlement is out as a first draft. Here is a sharp critique of the bill THE GOVERNMENT has made public the new Draft National Land Acquisition and Rehabilitation & Resettlement Bill, 2011, which FW has run in these columns over three days. This is what I think of it. In terms of the definition of public purpose, the Bill is more colonial...
More »SEARCH RESULT
Total Matching Records found : 1654
Aruna Roy, social activist interviewed by Shoma Chaudhury
The Lokpal Bill is in danger of skidding off the rails. As it is introduced in Parliament, eminent activist Aruna Roy tells Shoma Chaudhury why we should not rush into it. THE LOKPAL BILL is now being debated in Parliament, almost 40 years after the idea was first mooted. Unfortunately, parented on one side by decades of wilful government inertia and, on the other, by the panicked hustle of ‘Team...
More »The right to skills by Manish Sabharwal
It’s been raining “rights” in Indian policy for the last few years — education, work, food, service, healthcare, and much else. This “Diet Coke” approach to poverty reduction — the sweetness without the calories — was always dangerous because of unknown side effects. Commenting in 1790 on the consequences of the French Revolution, Edmund Burke said: “They have found their punishment in their success. Laws overturned, tribunals subverted, industry without...
More »State wary of Bengal olive branch to rebels by Suman K Shrivastava & Nishit Dholabhai
Jharkhand is viewing with serious concern Mamata Banerjee government’s peace initiatives with Maoists in neighbouring Bengal, the apprehensions centred around a prevalent lull in anti-rebel operations that could lead to repercussions in a state that the Union home minister described as the epicentre of left wing extremism. State DGP G.S. Rath believes the developments in Bengal, where peace moves have meant that anti-rebel operations have been reduced to routine patrolling by...
More »Useless pharmaceutical studies cause real harm by Carl Elliott
Last month, the Archives of Internal Medicine published a scathing reassessment of a 12-year-old research study of Neurontin, a seizure drug made byPfizer. The study, which had included more than 2,700 subjects and was carried out by Parke-Davis (now part of Pfizer), was notable for how poorly it was conducted. The investigators were inexperienced and untrained, and the design of the study was so flawed it generated few if any...
More »
